期刊文献+

大麻素受体1在大鼠非酒精性脂肪性肝病中的作用 被引量:1

Experimental study on role of cannabinoid receptor 1 in non-alcoholic fatty liver disease among rats
下载PDF
导出
摘要 目的动态观察内源性大麻素受体l(CB1)在大鼠非酒精性脂肪性肝病(NAFLD)中的表达,初步探讨CB1在NAFLD发病中的作用。方法雄性SD大鼠48只,随机分3组:对照组(普通饲料)、模型组(高糖高脂饲料)、干预组(高糖高脂饲料+利莫那班),分别于实验第4、8周末每组各取8只处死,测体重、计算肝指数,检测血清ALT、AST、甘油三酯(TG)、总胆固醇(TC);ELISA法检测血清瘦素(Leptin)、肿瘤坏死因子(TNF)α含量,肝组织HE染色,观察其病理形态变化,免疫组化染色法观察NAFLD不同阶段肝组织CB1表达。采用单因素方差分析对各组间进行比较,组间两两比较采用SNK-q检验,组内比较采用两独立样本t检验,两指标间的相关性采用Pearson直线相关分析法。结果 (1)模型组大鼠血清ALT、AST、TC、TG、Leptin及TNFα水平均较对照组及利莫那班组高(P<0.05);(2)肝组织学改变:模型组第4周呈单纯性脂肪肝改变,第8周呈弥漫性肝脂肪变伴炎细胞浸润,干预组较同期模型组肝病变减轻;(3)肝脏CB1免疫组织化学检测:对照组表达阴性;模型组和干预组表达呈阳性。通过积分光密度值比较,模型组高于同期干预组(P<0.05)。结论 CB1在NAFLD患者中表达增强,并可能与TNFα和Leptin共同作用促进NAFLD进展。 Objective To observe the expression of endogenous cannabinoid receptor l(CB1) in rats with non-alcoholic fatty liver disease(NAFLD) and to preliminarily investigate the role of CB1 receptors in the pathogenesis of NAFLD.Methods Forty-eight male SD rats were randomly divided into three groups: control group(receiving normal feed),model group(receiving high-sugar and high-fat feed),and rimonabant group(receiving high-sugar and high-fat feed and rimonabant).At the end of the 4th or 8th week of experiment,8 of each group were sacrificed.The body weight was measured,and the liver index was calculated.The serum levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST),triglyceride(TG),and total cholesterol(TC) were determined.The serum levels of leptin and tumor necrosis factor(TNF)α were determined by ELISA.The liver tissue was treated by HE staining,and the pathological changes were observed.Immunohistochemical staining was used to evaluate the CB1 receptor expression in liver tissues in different stages of NAFLD.One-way analysis of variance and t-test were used for within-group and between-group comparisons.Pearson′s linear-correlation analysis was used for evaluating the correlation between indices.Results The model group had significantly higher serum levels of ALT,AST,TC,TG,leptin,and TNF-α than the control group and rimonabant group(P0.05).The model group showed simple fatty degeneration of the liver after 4 weeks and diffuse fatty degeneration of the liver with inflammatory cell infiltration after 8 weeks,while the rimonabant group had less severe liver lesions at the same time.CB1 receptor expression was not detected in the control group,but was detected in the model group and rimonabant group,according to the immunohistochemical staining,and the model group had a significantly higher integral optical density than the rimonabant group(P0.05).Conclusion The expression of CB1 receptors is enhanced in patients with NAFLD,and it may act together w
出处 《临床肝胆病杂志》 CAS 2013年第8期611-615,共5页 Journal of Clinical Hepatology
关键词 脂肪肝 受体 大麻酚 CB1 瘦素 肿瘤坏死因子Α fatty liver receptor cannabinoid CB1 leptin tumor necrosis factor-alpha
  • 相关文献

参考文献6

二级参考文献19

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南.中华肝脏病杂志,2006,14(2):161-161. 被引量:23
  • 2Angulo P. Obesity and nonaleoholie fatty liver disease [ J ]. Nutr Rev ,2007,65 ( SI ) : $57 - 63. 被引量:1
  • 3Grant LM, Lisker MM. Nonalcoholic fatty liver disease [ J ]. Ann Hepatol,2004,3 ( 3 ) : 93 - 99. 被引量:1
  • 4Bedogni G, Bellentani S. Fatty liver, how frequent is it and why [ J ]. Ann Hepatol,2004,3(2) : 63 -65. 被引量:1
  • 5Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China [ J ]. J Hepatol, 2005,43 ( 3 ) : 508 - 514. 被引量:1
  • 6Gupte P, Amarapurkar D, Agal S, et al. Non - alcoholic steatohepatitis in type 2 diabetes mellitus[ J ]. Gastroenterol Hepatol,2004,19 (8) : 854 - 858. 被引量:1
  • 7Methta K,van Thiel DH, Shah N, et al. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants[ J]. Nutr Rev,2002, 60 ( 9 ) : 289 - 293. 被引量:1
  • 8Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States[ J]. Am J Gastroenterol, 2003,98 ( 5 ) : 960 - 967. 被引量:1
  • 9Schindhehn RK, Diamant M, Jacqueline M, et al. Alanine aminotransferase as a marker of non - alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease[J]. Diabetes Metab Res Rev,2006,22 ( 6 ) : 437 - 443. 被引量:1
  • 10Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease [ J ]. Clin Liver Dis,2004 ;8 (3):575 - 594. 被引量:1

共引文献1663

同被引文献13

  • 1Howlett A C. Pharmacology of Cannabinoid Receptors [J]. Annu Rev Pharmacol Toxicol, 1995, 35: 607-634. 被引量:1
  • 2Schwartz M W, Woods S C, Porte D J, et al. Central nervous system control of food intake[J]. Nature, 2000, 404: 661-671. 被引量:1
  • 3Ameri A, The effects of cannabinoid on the brain[J]. Prog Neurobiol, 1999, 58(4): 315-348. 被引量:1
  • 4Di M V, Goparaju S K, Wang L, et al. Leptin-regulated endoeannabinoids are involved in maintaining food intake [J]. Nature, 2001, 410: 822-825. 被引量:1
  • 5Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor [J]. FEBS Letters, 1994, 350(2-3): 240-244. 被引量:1
  • 6Fernandez-Ruiz J, Romero J, Velasco G, et al. Cannabinoid CB2 receptor: a new target for controlling neural cell survival [J]. Trends Pharmacol Sci, 2007, 28 (1): 39-45. 被引量:1
  • 7Whiteside G T, Gottshall S L, Boulet J M, et al. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833 [J]. Eur J Pharmaeol, 2005, 528(1-3): 65-72. 被引量:1
  • 8Aurore A, Marie-Paule G. The endocannabinoid system: Its roles in energy balance and potential as a target for obesity treatment [J]. Int J Biochem Cell Biol, 2010, 42 (11): 1788- 1801. 被引量:1
  • 9Rinaldi-Carmona M, Barth F, Millan J, et al. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor[J]. ASPET, 1998, 284: 644-650. 被引量:1
  • 10Balazs V, Ferenc K, Istvan G. Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats[J]. Pharmacol Biochem Be, 2012, 103: 425-430. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部